19 December 2016

Wellcome Trust Sanger Institute Spins Out New Company Microbiotica

IP Group plc (IPO), with Cambridge Innovation Capital plc, is spinning out a new company from the Wellcome Trust Sanger Institute to focus on the human microbiome. The new company will be called Microbiotica. The new company will establish laboratories within the Wellcome Genome Campus at Hinxton, Cambridge (UK). IP Group and Cambridge Innovation Capital each ponied up 4 million pounds for a total initial funding of 8 million pounds. The technology component of the company will be directed by Trevor Lawley, of The Sanger Institute, as chief scientific officer. Mike Romanos will be the chief executive officer. Romanos previously held senior roles at GlaxoSmithKline (GSK) and was the chief executive officer of Crescendo Biologics.  Source: Biospace 19/12/2017

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).